Customer Updates: Stryker Network Disruption > Read Now
Built on a strong foundation of innovation, high-quality products and rigorous clinical evidence, Inari became one of the defining forces in venous care. Now, as Stryker’s Peripheral Vascular business, that foundation has everything it needs to go further.
We lead fearlessly, with a portfolio that spans the treatment of venous and arterial diseases. We innovate intentionally, designing technology alongside clinicians. And we transform together, expanding access, deepening expertise and raising the standard of care globally.
Peripheral Vascular solutions
Pulmonary Embolism (PE)
Products designed to quickly remove clots from the lungs.
Deep Vein Thrombosis (DVT)
Versatile thrombectomy solutions that remove clot, restore venous flow and support improved patient outcomes.
In-Stent Thrombosis
Specialized solution to clear clot from venous stents, restore blood flow and improve vessel patency.
Small Venous Thrombectomy
Devices designed to remove clots insmaller veins, AV fistulas or grafts – restoring blood flow and enabling continued hemodialysis treatment.
Chronic Venous Occlusions
Innovative solution designed to address challenging venous occlusions, restore blood flow and improve patient quality of life.
Arterial Disease Solutions
Purpose-built technologies for acute arterial thrombus removal and limb salvage – restoring perfusion and creating new revascularization pathways for chronic limb-threatening ischemia (CLTI).
Clinical evidence
CLOUT Registry
The largest prospective mechanical thrombectomy study in the field of deep vein thrombosis (DVT).
DEFIANCE RCT
Randomized controlled trail (RCT) of ClotTriever vs. anticoagulation alone in deep vein thrombosis (DVT).
FLAME Study
The largest prospective study of interventional treatment in high-risk pulmonary embolism (PE).
FLASH Registry
The largest prospective interventional registry of pulmonary embolism (PE).
PEERLESS Study
The first randomized controlled trial (RCT) evaluating FlowTriever in the treatment of pulmonary embolism (PE).
PEERLESS II Study
Randomized controlled trial (RCT) of FlowTriever vs. anticoagulation alone in acute pulmonary embolism (PE).
PROMISE I Study
A multi-center, prospective, single-arm study conducted at 7 U.S. centers encompassing end-stage — or "no option" — CLTI patients.
PROMISE II Study
A multi-center, prospective, efficacy and safety study conducted at 10 U.S. centers encompassing end-stage — or "no option" — CLTI patients.
ArtixASCEND Study
The first prospective registry of Artix for the treatment of acute lower extremity arterial occlusions.
REVIT Study
The first prospective registry of RevCore for the treatment of in-stent thrombosis.
We don't just educate.
We elevate.
At Stryker, we put as much effort and energy into our education as we put into our high-tech, Med-Tech portfolio. The teaching is tailored. The knowledge is relevant. The impact is exponential.
Indications For Use: The FlowTriever Retrieval/Aspiration System is indicated for (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever Retrieval/Aspiration System is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever Catheters are indicated for (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Triever Catheters are intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever Catheters are also intended for use in treating clot in transit in the right atrium, but not in conjunction with the FlowTriever Catheters. The FlowTriever2 Catheter is indicated for (1) The non-surgical removal of emboli and thrombi from peripheral blood vessels. (2) Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever2 Catheter is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism (PE). The Triever20 Curve Catheter is used coaxially within the Triever24 Catheter for (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion, and/ or aspiration of contrast media and other fluids into or from a blood vessel. The Triever20 Curve Catheter is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever20 Curve Catheter is not indicated for use with the FlowTriever Catheters. The Triever20 Curve Catheter is also intended for use in treating clot in transit in the right atrium, but not in conjunction with the FlowTriever Catheters. The Triever20 Curve Catheter must be used within the Triever24 Catheter. The Triever16 Curve Catheter is indicated for (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Triever16 Curve Catheter is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism. The Triever16 Curve Catheter is not indicated for use with the FlowTriever Catheters. The Triever16 Curve Catheter is also intended for use in treating clot in transit in the right atrium but not in conjunction with the FlowTriever Catheters. The FlowSaver Blood Return System is used with Inari Medical catheters and sheaths for autologous blood transfusion. The FlowStasis Device is intended for temporary suture retention following a percutaneous venous procedure. The Intri24 Introducer Sheath is indicated to provide a conduit for the insertion of endovascular devices into the vasculature while minimizing blood loss associated with such insertions. The ClotTriever Thrombectomy System is indicated for: (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever Thrombectomy System is intended for use in the peripheral vasculature including deep vein thrombosis (DVT). The ClotTriever Sheaths are indicated for use as a conduit for the insertion of endovascular devices into the vasculature while minimizing blood loss associated with such insertions. The Protrieve Sheath is indicated for use as a conduit for the insertion of endovascular devices into the vasculature while minimizing blood loss associated with such insertions. The InThrill Thrombectomy System is indicated for (1) The non-surgical removal of thrombi and emboli from blood vessels, including arteriovenous fistulae and arteriovenous grafts for dialysis access, and synthetic grafts. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel/graft. The InThrill Thrombectomy System is intended for use in the peripheral vasculature. The InThrill Thrombectomy System is not intended for use in deep vein thrombosis (DVT) treatment. The RevCore Thrombectomy Catheter is indicated for (1) The non-surgical removal of thrombi and emboli from blood vessels (2) Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The RevCore Thrombectomy Catheter is intended for use in the peripheral vasculature. The VenaCore Thrombectomy Catheter is indicated for (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from blood vessels. The VenaCore Thrombectomy Catheter is intended for use in the peripheral vasculature.
Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
PRO-2742-USA-EN-v1